vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Liberty Energy Inc. (LBRT). Click either name above to swap in a different company.

Liberty Energy Inc. is the larger business by last-quarter revenue ($1.0B vs $138.3M, roughly 7.4× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 3.6% vs 2.2%, a 1.4% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (7.0% vs 4.5%). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (3.3% CAGR vs -6.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.

CLB vs LBRT — Head-to-Head

Bigger by revenue
LBRT
LBRT
7.4× larger
LBRT
$1.0B
$138.3M
CLB
Growing faster (revenue YoY)
CLB
CLB
+2.5% gap
CLB
7.0%
4.5%
LBRT
Higher net margin
CLB
CLB
1.4% more per $
CLB
3.6%
2.2%
LBRT
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
3.3%
-6.2%
LBRT

Income Statement — Q4 2025 vs Q1 2026

Metric
CLB
CLB
LBRT
LBRT
Revenue
$138.3M
$1.0B
Net Profit
$4.9M
$22.6M
Gross Margin
20.8%
Operating Margin
11.5%
2.2%
Net Margin
3.6%
2.2%
Revenue YoY
7.0%
4.5%
Net Profit YoY
-33.2%
64.8%
EPS (diluted)
$0.11
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
LBRT
LBRT
Q1 26
$1.0B
Q4 25
$138.3M
$1.0B
Q3 25
$134.5M
$947.4M
Q2 25
$130.2M
$1.0B
Q1 25
$123.6M
$977.5M
Q4 24
$129.2M
$943.6M
Q3 24
$134.4M
$1.1B
Q2 24
$130.6M
$1.2B
Net Profit
CLB
CLB
LBRT
LBRT
Q1 26
$22.6M
Q4 25
$4.9M
$13.7M
Q3 25
$14.2M
$43.1M
Q2 25
$10.6M
$71.0M
Q1 25
$-154.0K
$20.1M
Q4 24
$7.4M
$51.9M
Q3 24
$11.7M
$73.8M
Q2 24
$9.0M
$108.4M
Gross Margin
CLB
CLB
LBRT
LBRT
Q1 26
Q4 25
20.8%
20.6%
Q3 25
22.0%
18.7%
Q2 25
20.3%
22.1%
Q1 25
19.5%
22.1%
Q4 24
17.8%
21.4%
Q3 24
20.5%
26.2%
Q2 24
21.2%
27.9%
Operating Margin
CLB
CLB
LBRT
LBRT
Q1 26
2.2%
Q4 25
11.5%
1.9%
Q3 25
15.6%
-0.3%
Q2 25
11.7%
3.6%
Q1 25
3.6%
1.9%
Q4 24
11.0%
2.6%
Q3 24
14.7%
9.4%
Q2 24
12.3%
12.2%
Net Margin
CLB
CLB
LBRT
LBRT
Q1 26
2.2%
Q4 25
3.6%
1.3%
Q3 25
10.6%
4.5%
Q2 25
8.2%
6.8%
Q1 25
-0.1%
2.1%
Q4 24
5.7%
5.5%
Q3 24
8.7%
6.5%
Q2 24
6.9%
9.3%
EPS (diluted)
CLB
CLB
LBRT
LBRT
Q1 26
$0.14
Q4 25
$0.11
$0.08
Q3 25
$0.30
$0.26
Q2 25
$0.22
$0.43
Q1 25
$0.00
$0.12
Q4 24
$0.15
$0.31
Q3 24
$0.25
$0.44
Q2 24
$0.19
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
LBRT
LBRT
Cash + ST InvestmentsLiquidity on hand
$22.7M
$699.1M
Total DebtLower is stronger
$110.3M
$7.1M
Stockholders' EquityBook value
$266.0M
$1.9B
Total Assets
$584.0M
$4.4B
Debt / EquityLower = less leverage
0.41×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
LBRT
LBRT
Q1 26
$699.1M
Q4 25
$22.7M
$27.6M
Q3 25
$25.6M
$13.5M
Q2 25
$31.2M
$19.6M
Q1 25
$22.1M
$24.1M
Q4 24
$19.2M
$20.0M
Q3 24
$21.5M
$23.0M
Q2 24
$17.7M
$30.0M
Total Debt
CLB
CLB
LBRT
LBRT
Q1 26
$7.1M
Q4 25
$110.3M
$246.6M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
$190.5M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
LBRT
LBRT
Q1 26
$1.9B
Q4 25
$266.0M
$2.1B
Q3 25
$271.3M
$2.1B
Q2 25
$261.3M
$2.0B
Q1 25
$253.4M
$2.0B
Q4 24
$246.6M
$2.0B
Q3 24
$250.7M
$2.0B
Q2 24
$240.3M
$1.9B
Total Assets
CLB
CLB
LBRT
LBRT
Q1 26
$4.4B
Q4 25
$584.0M
$3.6B
Q3 25
$591.4M
$3.5B
Q2 25
$602.1M
$3.4B
Q1 25
$591.5M
$3.4B
Q4 24
$585.1M
$3.3B
Q3 24
$600.5M
$3.3B
Q2 24
$597.8M
$3.2B
Debt / Equity
CLB
CLB
LBRT
LBRT
Q1 26
0.00×
Q4 25
0.41×
0.12×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
0.10×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
LBRT
LBRT
Operating Cash FlowLast quarter
$7.9M
Free Cash FlowOCF − Capex
$5.0M
FCF MarginFCF / Revenue
3.6%
Capex IntensityCapex / Revenue
2.1%
13.1%
Cash ConversionOCF / Net Profit
1.61×
TTM Free Cash FlowTrailing 4 quarters
$25.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
LBRT
LBRT
Q1 26
Q4 25
$7.9M
$195.4M
Q3 25
$8.5M
$51.5M
Q2 25
$13.9M
$170.6M
Q1 25
$6.7M
$192.1M
Q4 24
$20.6M
$177.3M
Q3 24
$13.1M
$244.5M
Q2 24
$17.1M
$248.2M
Free Cash Flow
CLB
CLB
LBRT
LBRT
Q1 26
Q4 25
$5.0M
$-10.0M
Q3 25
$6.5M
$-67.2M
Q2 25
$10.4M
$33.1M
Q1 25
$3.9M
$58.2M
Q4 24
$17.4M
$-26.2M
Q3 24
$10.4M
$77.9M
Q2 24
$14.3M
$112.2M
FCF Margin
CLB
CLB
LBRT
LBRT
Q1 26
Q4 25
3.6%
-1.0%
Q3 25
4.8%
-7.1%
Q2 25
8.0%
3.2%
Q1 25
3.1%
6.0%
Q4 24
13.4%
-2.8%
Q3 24
7.7%
6.8%
Q2 24
10.9%
9.7%
Capex Intensity
CLB
CLB
LBRT
LBRT
Q1 26
13.1%
Q4 25
2.1%
19.8%
Q3 25
1.5%
12.5%
Q2 25
2.7%
13.2%
Q1 25
2.3%
13.7%
Q4 24
2.5%
21.6%
Q3 24
2.0%
14.6%
Q2 24
2.2%
11.7%
Cash Conversion
CLB
CLB
LBRT
LBRT
Q1 26
Q4 25
1.61×
14.28×
Q3 25
0.60×
1.20×
Q2 25
1.31×
2.40×
Q1 25
9.55×
Q4 24
2.78×
3.42×
Q3 24
1.12×
3.31×
Q2 24
1.90×
2.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Services$107.0M77%
Products$31.3M23%

LBRT
LBRT

Segment breakdown not available.

Related Comparisons